Ron Squarer - Net Worth and Insider Trading
Ron Squarer Net Worth
The estimated net worth of Ron Squarer is at least $10 Million dollars as of 2024-11-13. Ron Squarer is the CEO of Array BioPharma Inc and owns about 238,709 shares of Array BioPharma Inc (ARRY) stock worth over $9 Million. Ron Squarer is also the Director of ADC Therapeutics SA and owns about 80,663 shares of ADC Therapeutics SA (ADCT) stock worth over $236,343. Details can be seen in Ron Squarer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ron Squarer has not made any transactions after 2024-06-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ron Squarer
Ron Squarer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ron Squarer owns 2 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , and Travere Therapeutics Inc (TVTX) .
Click here to see the complete history of Ron Squarer’s form 4 insider trades.
Insider Ownership Summary of Ron Squarer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2019-12-04 | director |
| TVTX | Travere Therapeutics Inc | 2017-04-10 | director |
Ron Squarer Latest Holdings Summary
Ron Squarer currently owns a total of 2 stocks. Among these stocks, Ron Squarer owns 238,709 shares of Array BioPharma Inc (ARRY) as of February 7, 2019, with a value of $9 Million and a weighting of 97.52%. Ron Squarer also owns 80,663 shares of ADC Therapeutics SA (ADCT) as of June 17, 2024, with a value of $236,343 and a weighting of 2.48%.
Latest Holdings of Ron Squarer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARRY | Array BioPharma Inc | 2019-02-07 | 238,709 | 38.95 | 9,297,716 |
| ADCT | ADC Therapeutics SA | 2024-06-17 | 80,663 | 2.93 | 236,343 |
Holding Weightings of Ron Squarer
Ron Squarer Form 4 Trading Tracker
According to the SEC Form 4 filings, Ron Squarer has made a total of 0 transactions in Array BioPharma Inc (ARRY) over the past 5 years. The most-recent trade in Array BioPharma Inc is the sale of 110,000 shares on February 7, 2019, which brought Ron Squarer around $2 Million.
According to the SEC Form 4 filings, Ron Squarer has made a total of 1 transactions in ADC Therapeutics SA (ADCT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in ADC Therapeutics SA is the sale of 6,995 shares on June 17, 2024, which brought Ron Squarer around $20,216.
Insider Trading History of Ron Squarer
- 1
Ron Squarer Trading Performance
Ron Squarer Ownership Network
Ownership Network List of Ron Squarer
Ownership Network Relation of Ron Squarer
Ron Squarer Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Ron Squarer is the director of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include SVP & Regulatory & Quality Jama Pitman , Chief Commercial Officer Daniel C. Martin , and Chief Financial Officer Thomas Patrick Kelly .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Ron Squarer made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 12,184 shares made by Matthew L Sherman , and a net sale of 9,198 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 105,002 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 95,002 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Ron Squarer Mailing Address
Above is the net worth, insider trading, and ownership report for Ron Squarer. You might contact Ron Squarer via mailing address: C/o Adc Therapeutics Sa, Biopole, Route De La Corniche 3b, Epalinges V8 1066.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
